BR0009159A - Método de controle do ganho de peso associadocom drogas terapêuticas - Google Patents
Método de controle do ganho de peso associadocom drogas terapêuticasInfo
- Publication number
- BR0009159A BR0009159A BR0009159-6A BR0009159A BR0009159A BR 0009159 A BR0009159 A BR 0009159A BR 0009159 A BR0009159 A BR 0009159A BR 0009159 A BR0009159 A BR 0009159A
- Authority
- BR
- Brazil
- Prior art keywords
- weight gain
- therapeutic drugs
- control method
- gain control
- method associated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"MéTODO DE CONTROLE DO GANHO DE PESO ASSOCIADOCOM DROGAS TERAPêUTICAS". Um composto de fórmula (I) ouum sal farmaceuticamente aceitável dele proveniente no qual R~1~ e R~ 2~ são independentemente H ou metila (por exemplo, ocloridrato de<UM>N,N<MV>-dimetil-1-[1-(4-clorofenil)ciclobutil]-3-metilbutilaminaopcionalmente na forma de seu monohidrato), é usado para otratamento do ganho de peso associado com o tratamento comcertas terapias com drogas, incluindo o uso de antidepressivostricíclicos, lítio, sulfoniluréias, bloqueadores beta-adrenérgicos,certos esteróides contraceptivos, corticosteróides, insulina,ciproheptadina, valproato de sódio, neuroléticos, fenotiazina oupiztifen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12534099P | 1999-03-19 | 1999-03-19 | |
PCT/US2000/007130 WO2000056313A1 (en) | 1999-03-19 | 2000-03-17 | Method of controlling weight gain associated with therapeutic drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0009159A true BR0009159A (pt) | 2001-12-26 |
Family
ID=22419292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0009159-6A BR0009159A (pt) | 1999-03-19 | 2000-03-17 | Método de controle do ganho de peso associadocom drogas terapêuticas |
Country Status (20)
Country | Link |
---|---|
US (1) | US6376552B1 (pt) |
EP (1) | EP1162965A1 (pt) |
JP (1) | JP2002539251A (pt) |
KR (1) | KR20020000784A (pt) |
CN (1) | CN1353603A (pt) |
AU (1) | AU3757800A (pt) |
BG (1) | BG105997A (pt) |
BR (1) | BR0009159A (pt) |
CA (1) | CA2367021A1 (pt) |
CZ (1) | CZ291864B6 (pt) |
HU (1) | HUP0200393A2 (pt) |
IL (1) | IL145241A0 (pt) |
MX (1) | MXPA01009467A (pt) |
NO (1) | NO20014480L (pt) |
NZ (1) | NZ514009A (pt) |
PL (1) | PL350919A1 (pt) |
SK (1) | SK13352001A3 (pt) |
TR (1) | TR200102695T2 (pt) |
WO (1) | WO2000056313A1 (pt) |
ZA (1) | ZA200107692B (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002019998A2 (en) * | 2000-09-08 | 2002-03-14 | Eli Lilly And Company | A method of treating weight gain associated with atypical antipsychotic use |
BR0315084A (pt) * | 2002-10-05 | 2005-08-16 | Hanmi Pharm Ind Co Ltd | Composição farmacêutica compreendendo hemiidrato cristalino de metanossulfonato de sibutramina |
US20050131074A1 (en) * | 2003-08-04 | 2005-06-16 | Beckman Kristen M. | Methods for treating metabolic syndrome |
US20060035827A1 (en) * | 2004-06-24 | 2006-02-16 | Green Gary M | Compositions and methods for the treatment or prevention of gallbladder disease |
KR20060080818A (ko) | 2005-01-06 | 2006-07-11 | 씨제이 주식회사 | 시부트라민의 술폰산염 |
KR20060080817A (ko) | 2005-01-06 | 2006-07-11 | 씨제이 주식회사 | 시부트라민의 디카복실산염 |
JP2008526836A (ja) * | 2005-01-06 | 2008-07-24 | シージェー チェイルジェダン コーポレーション | シブトラミンの無機酸塩 |
KR20060093564A (ko) * | 2005-02-22 | 2006-08-25 | 종근당바이오 주식회사 | 무수 시부트라민 말산염 및 이의 제조 방법 |
KR100627687B1 (ko) * | 2005-04-20 | 2006-09-25 | 주식회사 씨티씨바이오 | 시부트라민 유리염기 함유 조성물 및 이의 제조방법 |
JP2010503709A (ja) * | 2006-09-15 | 2010-02-04 | レビバ ファーマシューティカルズ,インコーポレーテッド | シクロアルキルメチルアミンの合成、使用方法および組成物 |
BRPI0716002A2 (pt) * | 2006-11-22 | 2013-07-30 | Sk Chemicals Co Ltd | complexo de inclusço, processo de preparaÇço de um complexo de inclusço e composiÇço de tratamento e prevenÇço de hipocondria e obesidade |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2675573B2 (ja) * | 1988-03-31 | 1997-11-12 | 科研製薬株式会社 | 脳機能改善剤 |
IE61928B1 (en) * | 1988-11-29 | 1994-11-30 | Boots Co Plc | Treatment of obesity |
US5459164A (en) * | 1994-02-03 | 1995-10-17 | Boots Pharmaceuticals, Inc. | Medical treatment |
-
2000
- 2000-03-17 CN CN00807688A patent/CN1353603A/zh active Pending
- 2000-03-17 CA CA002367021A patent/CA2367021A1/en not_active Abandoned
- 2000-03-17 WO PCT/US2000/007130 patent/WO2000056313A1/en not_active Application Discontinuation
- 2000-03-17 JP JP2000606218A patent/JP2002539251A/ja not_active Withdrawn
- 2000-03-17 AU AU37578/00A patent/AU3757800A/en not_active Abandoned
- 2000-03-17 IL IL14524100A patent/IL145241A0/xx unknown
- 2000-03-17 NZ NZ514009A patent/NZ514009A/xx not_active Application Discontinuation
- 2000-03-17 TR TR2001/02695T patent/TR200102695T2/xx unknown
- 2000-03-17 KR KR1020017011925A patent/KR20020000784A/ko not_active Application Discontinuation
- 2000-03-17 MX MXPA01009467A patent/MXPA01009467A/es unknown
- 2000-03-17 PL PL00350919A patent/PL350919A1/xx not_active Application Discontinuation
- 2000-03-17 US US09/527,962 patent/US6376552B1/en not_active Expired - Fee Related
- 2000-03-17 CZ CZ20013283A patent/CZ291864B6/cs not_active IP Right Cessation
- 2000-03-17 SK SK1335-2001A patent/SK13352001A3/sk unknown
- 2000-03-17 HU HU0200393A patent/HUP0200393A2/hu unknown
- 2000-03-17 BR BR0009159-6A patent/BR0009159A/pt not_active Application Discontinuation
- 2000-03-17 EP EP00916480A patent/EP1162965A1/en not_active Withdrawn
-
2001
- 2001-09-14 NO NO20014480A patent/NO20014480L/no unknown
- 2001-09-18 ZA ZA200107692A patent/ZA200107692B/en unknown
- 2001-10-10 BG BG105997A patent/BG105997A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2367021A1 (en) | 2000-09-28 |
WO2000056313A1 (en) | 2000-09-28 |
IL145241A0 (en) | 2002-06-30 |
ZA200107692B (en) | 2002-12-18 |
BG105997A (en) | 2002-06-28 |
PL350919A1 (en) | 2003-02-10 |
AU3757800A (en) | 2000-10-09 |
CZ291864B6 (cs) | 2003-06-18 |
JP2002539251A (ja) | 2002-11-19 |
SK13352001A3 (sk) | 2002-03-05 |
MXPA01009467A (es) | 2004-03-19 |
KR20020000784A (ko) | 2002-01-05 |
EP1162965A1 (en) | 2001-12-19 |
TR200102695T2 (tr) | 2002-01-21 |
CN1353603A (zh) | 2002-06-12 |
NZ514009A (en) | 2001-09-28 |
NO20014480D0 (no) | 2001-09-14 |
NO20014480L (no) | 2001-11-02 |
HUP0200393A2 (en) | 2002-08-28 |
US6376552B1 (en) | 2002-04-23 |
CZ20013283A3 (cs) | 2002-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2260043T3 (es) | Combinacion sinergica de roflumilast y salmeterol. | |
GB9902689D0 (en) | Organic compounds | |
BR0009159A (pt) | Método de controle do ganho de peso associadocom drogas terapêuticas | |
ES2230378T3 (es) | Combinacion de agonistas de gaba e inhibidores de sorbitol deshidrogenasa. | |
AR037255A1 (es) | Composiciones farmaceuticas que contienen oxibutinina | |
HUP0001894A2 (hu) | N-Piperidino-3-pirazolkarboxamid-származékot, sóját vagy szolvátját tartalmazó orálisan adagolható gyógyszerkészítmény | |
BRPI0108977B8 (pt) | compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo | |
BR122012014331A8 (pt) | Formulações farmacêuticas | |
ES2208870T3 (es) | Uso de antagonistas del receptor 5ht4 para resolver los efectos gastrointestinales de los inhibidores de la reabsorcion de serotonina. | |
JP2006517969A (ja) | 免疫炎症性障害の治療のための組み合わせ療法 | |
BR9711414A (pt) | Processo e composições farmacêuticas para abaixamento do nìvel de ácido úrico no organismo humano e para profilaxia da gota, hiperuricemia ou doença cardìaca coronária em humanos, e, uso de um composto | |
ES2226281T3 (es) | Tratamiento de la impotencia debida a lesiones de la medula espinal. | |
KR940008677A (ko) | 자기 면역 질환 치료약 | |
EP0337136A3 (en) | Piperidine derivatives in the treatment of extrapyramidal side effects associated with neuroleptic therapy | |
KR0178762B1 (ko) | 특정 인돌 유도체의 신규 의약적 용도 및 그를 함유하는 제약 조성물 | |
US20060247257A1 (en) | Combination | |
KR20050026091A (ko) | 항혈관형성 요법에 반응하는 질환의 치료에 유용한 화합물 | |
DK0421297T3 (da) | Injicerbare præparater indeholdende cephalosporin som lægemiddel og anvendelse deraf | |
JP2008533110A (ja) | カンナビノイド受容体アンタゴニスト化合物および抗精神病薬剤の組合せを含有する医薬組成物 | |
US4994457A (en) | Antiinflammatory compositions and methods | |
US6340696B1 (en) | Viral treatment | |
BR9910185A (pt) | Uso de um composto, e, processo para o tratamento de um paciente que sofre de, ou em risco de, uma doença micobacteriana | |
US6281213B1 (en) | Aversive treatment of stimulant abuse | |
US3852448A (en) | N-substituted amino-n-nitroso-aminoacetonitriles for treating hypertension | |
BR9912008A (pt) | Método de tratamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |